JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
210 hedge funds and large institutions have $3.62B invested in Juno Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 64 increasing their positions, 55 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
16% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 55
11% less call options, than puts
Call options by funds: $63.4M | Put options by funds: $71.6M
Holders
210
Holding in Top 10
7
Calls
$63.4M
Puts
$71.6M
Top Buyers
| 1 | +$256M | |
| 2 | +$59.9M | |
| 3 | +$55.2M | |
| 4 |
O
OrbiMed
New York
|
+$50.5M |
| 5 |
D.E. Shaw & Co
New York
|
+$41.1M |
Top Sellers
| 1 | -$360M | |
| 2 | -$66.3M | |
| 3 | -$35M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$25.4M |
| 5 |
Millennium Management
New York
|
-$18.6M |